WASHINGTON — President Trump nominated a pharmaceutical executive to be the next secretary of the Health and Human Services Department.
Mr. Azar’s nomination is likely to raise questions about Mr. Trump’s commitment to pressuring drug companies to lower prices in the United States. Last month, Mr. Trump accused drug companies of “getting away with murder” by charging more for their drugs in the United States than elsewhere in the world.
The nominee, Alex M. Azar II, served as a deputy at the department under former President George W. Bush. Until January, he was the head of the pharmaceutical company Eli Lilly’s United States division.
Mr. Trump made his announcement in a Twitter post while traveling in Asia. Mr. Trump said Mr. Azar would be “a star for better healthcare and lower drug prices!”
https://www.nytimes.com/2017/11/13/us/politics/alex-azar-health-human-services-trump.html
Mr. Azar’s nomination is likely to raise questions about Mr. Trump’s commitment to pressuring drug companies to lower prices in the United States. Last month, Mr. Trump accused drug companies of “getting away with murder” by charging more for their drugs in the United States than elsewhere in the world.
The nominee, Alex M. Azar II, served as a deputy at the department under former President George W. Bush. Until January, he was the head of the pharmaceutical company Eli Lilly’s United States division.
Mr. Trump made his announcement in a Twitter post while traveling in Asia. Mr. Trump said Mr. Azar would be “a star for better healthcare and lower drug prices!”
https://www.nytimes.com/2017/11/13/us/politics/alex-azar-health-human-services-trump.html
